register

Digital & Innovation

CSIRO discussion paper on the ethics of AI

Health Industry Hub | April 16, 2019 |

Artificial Intelligence (AI) has the potential to provide social, economic, and environmental benefits. For Australia to realise these benefits, it’s important for citizens to have trust in how AI is being designed, developed and used by business and government.

The CSIRO are seeking your views on a discussion paper to inform the Government’s approach to AI ethics in Australia. The discussion paper was developed by CSIRO’s Data61 and designed to encourage conversations about AI ethics in Australia.

The paper and your feedback will help the CSIRO ensure AI is developed and applied responsibly in Australia.

The Ethics Framework research was funded by the government in the 2018 May Budget. The work was guided by a steering committee of experts from industry, government and community organisations as well as researchers from CSIRO and Data61. Consultative workshops were also held in Sydney, Brisbane, Melbourne and Perth during 2018.


Medical and Science

NACCHO-Pfizer partnership ignites global journey for First Nations pharmacy leaders

NACCHO-Pfizer partnership ignites global journey for First Nations pharmacy leaders

Health Industry Hub | September 6, 2024 |

Medical & Science: NACCHO has announced the recipients of the 2024 Aboriginal and Torres Strait Islander Pharmacy Leadership Grant: Jes […]

More


ESG

First report exposes glaring gaps in healthcare sector sustainability

First report exposes glaring gaps in healthcare sector sustainability

Health Industry Hub | September 6, 2024 |

ESG: The first comprehensive report outlining sustainability and decarbonisation efforts in the Australian healthcare sector has been released, aimed at […]

More


News & Trends - Pharmaceuticals

Expanded access to Shingrix is a start: 'We need reform for all current and future vaccines'

Expanded access to Shingrix is a start: ‘We need reform for all current and future vaccines’

Health Industry Hub | September 6, 2024 |

Pharma News: Access to GSK’s Shingrix vaccine, following the 2023-24 federal budget decision, has been limited to “immunocompromised patients aged […]

More


News & Trends - Pharmaceuticals

NSW government fails to back mental health inquiry findings with essential funding

NSW government fails to back mental health inquiry findings with essential funding

Health Industry Hub | September 6, 2024 |

NSW Government has support for 24 of 39 recommendations from the Portfolio Committee’s Inquiry Report on ‘Equity, accessibility and appropriate […]

More


This content is copyright protected. Please subscribe to gain access.